COVID-19 revisited: Where does nirmatrelvir/ritonavir fit?

At a Pfizer-sponsored symposium held during WONCA Asia Pacific Conference 2024 in Singapore, renowned experts discussed COVID-19 vaccines and highlighted the need for effective antivirals in high-risk groups, including for older adults, with a special focus on the oral antiviral pill nirmatrelvir/ritonavir.

Resources

COVID-19 revisited: Where does nirmatrelvir/ritonavir fit?

Open PDF

COVID-19 revisited: Where does nirmatrelvir/ritonavir fit?

Open PDF